154 related articles for article (PubMed ID: 23802087)
1. Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort.
Prada N; Antoni G; Commo F; Rusakiewicz S; Semeraro M; Boufassa F; Lambotte O; Meyer L; Gougeon ML; Zitvogel L
Oncoimmunology; 2013 Mar; 2(3):e23472. PubMed ID: 23802087
[TBL] [Abstract][Full Text] [Related]
2. B7-H6-mediated downregulation of NKp30 in natural killer cells contributes to HIV-2 immune escape.
Lucar O; Sadjo Diallo M; Bayard C; Samri A; Tarantino N; Debré P; Thiébaut R; Brun-Vézinet F; Matheron S; Cheynier R; Vieillard V;
AIDS; 2019 Jan; 33(1):23-32. PubMed ID: 30325780
[TBL] [Abstract][Full Text] [Related]
3. Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype.
Bhardwaj S; Ahmad F; Wedemeyer H; Cornberg M; Schulze Zur Wiesch J; van Lunzen J; Sarin SK; Schmidt RE; Meyer-Olson D
Virol J; 2016 Apr; 13():67. PubMed ID: 27091211
[TBL] [Abstract][Full Text] [Related]
4. Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.
Lima JF; Oliveira LM; Pereira NZ; Mitsunari GE; Duarte AJ; Sato MN
J Acquir Immune Defic Syndr; 2014 Dec; 67(5):463-71. PubMed ID: 25230289
[TBL] [Abstract][Full Text] [Related]
5. CD56
Judge CJ; Kostadinova L; Sherman KE; Butt AA; Falck-Ytter Y; Funderburg NT; Landay AL; Lederman MM; Sieg SF; Sandberg JK; Anthony DD
J Leukoc Biol; 2017 Jul; 102(1):171-184. PubMed ID: 28400540
[TBL] [Abstract][Full Text] [Related]
6. An NK Cell Population Lacking FcRγ Is Expanded in Chronically Infected HIV Patients.
Zhou J; Amran FS; Kramski M; Angelovich TA; Elliott J; Hearps AC; Price P; Jaworowski A
J Immunol; 2015 May; 194(10):4688-97. PubMed ID: 25855354
[TBL] [Abstract][Full Text] [Related]
7. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals.
Tarazona R; Casado JG; Delarosa O; Torre-Cisneros J; Villanueva JL; Sanchez B; Galiani MD; Gonzalez R; Solana R; Peña J
J Clin Immunol; 2002 May; 22(3):176-83. PubMed ID: 12078859
[TBL] [Abstract][Full Text] [Related]
8. Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma.
Mantovani S; Oliviero B; Lombardi A; Varchetta S; Mele D; Sangiovanni A; Rossi G; Donadon M; Torzilli G; Soldani C; Porta C; Pedrazzoli P; Chiellino S; Santambrogio R; Opocher E; Maestri M; Bernuzzi S; Rossello A; Clément S; De Vito C; Rubbia-Brandt L; Negro F; Mondelli MU
Hepatology; 2019 Mar; 69(3):1165-1179. PubMed ID: 30153337
[TBL] [Abstract][Full Text] [Related]
9. Altered Expression of Natural Cytotoxicity Receptors and NKG2D on Peripheral Blood NK Cell Subsets in Breast Cancer Patients.
Nieto-Velázquez NG; Torres-Ramos YD; Muñoz-Sánchez JL; Espinosa-Godoy L; Gómez-Cortés S; Moreno J; Moreno-Eutimio MA
Transl Oncol; 2016 Oct; 9(5):384-391. PubMed ID: 27641642
[TBL] [Abstract][Full Text] [Related]
10. Human CD56
Amand M; Iserentant G; Poli A; Sleiman M; Fievez V; Sanchez IP; Sauvageot N; Michel T; Aouali N; Janji B; Trujillo-Vargas CM; Seguin-Devaux C; Zimmer J
Front Immunol; 2017; 8():699. PubMed ID: 28674534
[TBL] [Abstract][Full Text] [Related]
11. Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro.
Golden-Mason L; Cox AL; Randall JA; Cheng L; Rosen HR
Hepatology; 2010 Nov; 52(5):1581-9. PubMed ID: 20812318
[TBL] [Abstract][Full Text] [Related]
12. Persistence of pathological distribution of NK cells in HIV-infected patients with prolonged use of HAART and a sustained immune response.
Frias M; Rivero-Juarez A; Gordon A; Camacho A; Cantisan S; Cuenca-Lopez F; Torre-Cisneros J; Peña J; Rivero A
PLoS One; 2015; 10(3):e0121019. PubMed ID: 25811634
[TBL] [Abstract][Full Text] [Related]
13. Non-fitness status of peripheral NK cells defined by decreased NKp30 and perforin, and increased soluble B7H6, in cervical cancer patients.
Gutierrez-Silerio GY; Bueno-Topete MR; Vega-Magaña AN; Bastidas-Ramirez BE; Gutierrez-Franco J; Escarra-Senmarti M; Pedraza-Brindis EJ; Peña-Rodriguez M; Ramos-Marquez ME; Delgado-Rizo V; Banu N; Alejandre-Gonzalez AG; Fafutis-Morris M; Haramati J; Del Toro-Arreola S
Immunology; 2023 Mar; 168(3):538-553. PubMed ID: 36271832
[TBL] [Abstract][Full Text] [Related]
14. Terminal Differentiation of CD56(dim)CD16(+) Natural Killer Cells Is Associated with Increase in Natural Killer Cell Frequencies After Antiretroviral Treatment in HIV-1 Infection.
Ahmad F; Tufa DM; Mishra N; Jacobs R; Schmidt RE
AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1206-12. PubMed ID: 26352913
[TBL] [Abstract][Full Text] [Related]
15. Timing of Antiretroviral Therapy Initiation Determines Rectal Natural Killer Cell Populations.
Utay NS; Vigil KJ; Somasunderam A; Aulicino PC; Smulevitz B; Chiadika S; Wolf DS; Kimata JT; Arduino RC
AIDS Res Hum Retroviruses; 2020 Apr; 36(4):314-323. PubMed ID: 31838858
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients.
Semeraro M; Rusakiewicz S; Minard-Colin V; Delahaye NF; Enot D; Vély F; Marabelle A; Papoular B; Piperoglou C; Ponzoni M; Perri P; Tchirkov A; Matta J; Lapierre V; Shekarian T; Valsesia-Wittmann S; Commo F; Prada N; Poirier-Colame V; Bressac B; Cotteret S; Brugieres L; Farace F; Chaput N; Kroemer G; Valteau-Couanet D; Zitvogel L
Sci Transl Med; 2015 Apr; 7(283):283ra55. PubMed ID: 25877893
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection.
Mavilio D; Lombardo G; Kinter A; Fogli M; La Sala A; Ortolano S; Farschi A; Follmann D; Gregg R; Kovacs C; Marcenaro E; Pende D; Moretta A; Fauci AS
J Exp Med; 2006 Oct; 203(10):2339-50. PubMed ID: 17000867
[TBL] [Abstract][Full Text] [Related]
18. The early expansion of anergic NKG2A
Roberto A; Di Vito C; Zaghi E; Mazza EMC; Capucetti A; Calvi M; Tentorio P; Zanon V; Sarina B; Mariotti J; Bramanti S; Tenedini E; Tagliafico E; Bicciato S; Santoro A; Roederer M; Marcenaro E; Castagna L; Lugli E; Mavilio D
Haematologica; 2018 Aug; 103(8):1390-1402. PubMed ID: 29700172
[TBL] [Abstract][Full Text] [Related]
19. Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age.
Campos C; López N; Pera A; Gordillo JJ; Hassouneh F; Tarazona R; Solana R
Biogerontology; 2015 Oct; 16(5):671-83. PubMed ID: 25991472
[TBL] [Abstract][Full Text] [Related]
20. Expression of activating receptors on natural killer cells from AIDS-related lymphoma patients.
Mercier-Bataille D; Sanchez C; Baier C; Le Treut T; Mounier N; Mokhtari S; Olive D; Baumstarck K; Sébahoun G; Besson C; Costello RT
AIDS Res Ther; 2014; 11():38. PubMed ID: 25908934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
